BPC-157

The current research on BPC-157 consists primarily of laboratory and animal studies, with limited clinical trial data available. Here's what the key papers show:

Animal Studies:
Several recent animal studies have explored BPC-157's effects in rats. One 2026 study examined its cytoprotective (cell-protecting) effects in rats after unilateral adrenalectomy (surgical removal of one adrenal gland). Another study investigated its protective effects in rats with experimentally induced ischemia-reperfusion injury in the lower extremities - a condition where blood flow is cut off and then restored, potentially causing tissue damage.

Laboratory Research:
Research has examined BPC-157's potential mechanisms of action. A 2026 study published in the Journal of Clinical Medicine investigated how BPC-157 affects blood vessel relaxation in human internal mammary artery tissue, finding it may work through nitric oxide pathways that depend on the endothelium (blood vessel lining). Additional research has looked at BPC-157 and related compounds as potential inhibitors of acetylcholinesterase, an enzyme involved in nerve signaling.

Pharmaceutical Development:
A 2026 review in Pharmaceutics highlighted significant challenges in developing BPC-157 as a therapeutic, including biopharmaceutical hurdles, formulation difficulties, and barriers to clinical translation. The authors noted these development challenges as important considerations for moving the peptide from laboratory research to clinical applications.

Clinical Trials:
Only two clinical trials are currently documented. One Phase 1 safety and pharmacokinetics study (NCT02637284) has unknown status. A Phase 2 trial examining BPC-157 for acute hamstring muscle strain repair is reportedly recruiting participants (NCT07437547), though detailed results are not yet available.

The evidence base remains limited, consisting mainly of animal studies and preliminary research. Robust human clinical data demonstrating safety and efficacy for specific conditions is currently lacking.